Meet Our M&A Team Leaders
June 23, 2026 No Comments
Our newly established corporate finance and transaction management division is led by four dedicated specialists: Luka Macak, Nikola Pavlovic, Milica Stankovic and Tijana Nikolic.
Creating New Values
We target new small companies in Biotech industry with growth potential and good business ideas.
Control acquisitions of sub-scaled, under-managed, owner-operated companies.
Merger & acquisition, buyouts, joint venture partnership.
Typically $0,1M to $5M with flexibility to pursue outside of this range.
The controlling investor seeks a substantial majority ownership stake.
We are a highly active, deeply engaged, majority board member.
As an operationally-focused private investment firm, we specialize in the strategic investments, buyouts, and consolidation of high-performing Biotech startups based in Serbia leveraging our expertise and resources to unlock their full potential and drive sustainable growth.
As experienced professionals in Project developing, investments, and company growth consolidation, as well as scaling company to other markets , we recognize and appreciate the success you’ve achieved thus far. We also understand the challenges of scaling your business to the next level, maintaining its legacy, providing growth opportunities for you and your team.
By partnering with us, you can leverage our expertise, resources, and industry connections to achieve these goals and take your company to new heights of success.
Our goal is to unlock the full potential of your business by strategically placing the right people in the right roles and providing them with the resources and support they need to excel.
Through this process, we transform entrepreneurial businesses into thriving, resilient, and professionally managed organizations that create long-term value for all stakeholders.
Our newly established corporate finance and transaction management division is led by four dedicated specialists: Luka Macak, Nikola Pavlovic, Milica Stankovic and Tijana Nikolic.
Mr. Bojan Milovanović will personally oversee and coordinate the activities of the M&A team, establishing a vital strategic bridge between Biotech VC Partners and its current and future portfolio companies. Utilizing his extensive, multi-year entrepreneurial background, Mr. Milovanović will spearhead the firm’s deal-sourcing pipeline, leveraging his sharp market intuition to identify and capitalize on high-potential investment opportunities at an early stage.
Bojan Milovanović, CEO & Founder of Biotech VC Partners, emphasized the long-term importance of this expansion:
“The completion of our specialized M&A team is a pivotal step toward achieving our long-term strategic objectives and scaling our operational footprint. We are genuinely thrilled to welcome these exceptional professionals who have chosen to align their expertise with our vision from the early foundational chapters of our journey.
Biotech VC Partners is pleased to announce the establishment of our M&A (Mergers & Acquisitions) team. This strategic milestone brings top-tier expertise in corporate finance, legal and strategic advisory, and transaction execution specifically tailored to the biotechnology, pharmacy, and high-growth technology sectors.
Ready to scale up?
Partner with Biotech VCP for strategic investment and take your business to the next level.
Pich us at: